Screening for lung cancer based on individual risk can save more lives than the current U.S. Preventive Services Task Force (USPSTF) guidelines, reveals a new study.
The findings are published in Annals of Internal Medicine.
Lung Cancer Screening
Lung cancer accounts for nearly 1.3 million deaths annually worldwide. Lung cancer screening can help in early detection of cancer and possible cure.
Advertisement
‘Using the Lung Cancer Risk Assessment Tool can reduce the number of lung cancer deaths.’
Tweet it Now
The USPSTF recommends annual lung cancer screening with low-dose computed tomography (CT) for persons aged 55 to 80 years who currently smoke or quit within the past 15 years and have at least a 30-pack-year history of cigarette smoking.
These criteria may miss smokers at high risk for lung cancer who would have been selected for CT screening by individual risk calculators that more specifically account for demographic, clinical, and smoking characteristics.
![EU to Start Planning for Lung Cancer Screening]( "EU to Start Planning for Lung Cancer Screening")
The EUPS provides Europe with a detailed 18 month time-line to implement lung cancer screening that will have an enormous impact on the disease.
Researchers from the National Cancer Institute used data from the National Health Interview Survey to compare USPSTF eligibility criteria with individualized, risk-based eligibility and estimate the effect of eligibility on lung cancer deaths preventable by screening since 2005.
They found that using the Lung Cancer Risk Assessment Tool would draw in high-risk moderate smokers with a history of 20 to 29 pack-years who are currently ineligible for screening using USPSTF criteria.
This approach could have prevented over 5,000 more deaths in 2015 than using the USPSTF screening criteria. Because of the U.S. population changes related to smoking between 2010 and 2015, adhering to the USPSTF criteria led to fewer ever-smokers being eligible for CT screening and fewer lung cancer deaths being averted by screening.
Source: Eurekalert
EU to Start Planning for Lung Cancer Screening
The EUPS provides Europe with a detailed 18 month time-line to implement lung cancer screening that will have an enormous impact on the disease.
Advertisement
Researchers from the National Cancer Institute used data from the National Health Interview Survey to compare USPSTF eligibility criteria with individualized, risk-based eligibility and estimate the effect of eligibility on lung cancer deaths preventable by screening since 2005.
They found that using the Lung Cancer Risk Assessment Tool would draw in high-risk moderate smokers with a history of 20 to 29 pack-years who are currently ineligible for screening using USPSTF criteria.
This approach could have prevented over 5,000 more deaths in 2015 than using the USPSTF screening criteria. Because of the U.S. population changes related to smoking between 2010 and 2015, adhering to the USPSTF criteria led to fewer ever-smokers being eligible for CT screening and fewer lung cancer deaths being averted by screening.
Source: Eurekalert
New Breathalyzer Shows Promise for Lung Cancer Screening
Scientists in China announce that they have been working on a sensor able to detect volatile organic compounds in a person's breath that point to the existence of lung cancer.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
The presence of painless swelling in the lymph nodes could potentially indicate lymphatic cancer, say experts.
Women tested at high risk for breast cancer using non-clinical genetic tests overlooking family history may decide to undergo unnecessary breast surgery.
